http://www.who.int/vaccine_research/documents/IVR_IPR_Tokyo_Session1_Kaplan_presentation.pdf worth reading
I have to go through my saved searches I think I have another.
This has links to other mentions of "secrets" that are allowed to be kept -
An Access to Information request to Health Canada for the 100% composition of vaccines given to infants received the response, "I regret to inform you that the exact composition of these vaccines cannot be disclosed to you as the information is protected under ATIA (Access to Information Act) Section 20(1)(a)(b)(c). This is a mandatory exemption which protects confidential business information."
The Act, under Third Party Information, states, 20. (1) Subject to this section, the head of a government institution shall refuse to disclose any record requested under this Act that contains a) trade secrets of a third party; b) financial, commercial, scientific or technical information that is confidential information supplied to a government institution by a third party and is treated consistently in a confidential manner by the third party; c) information the disclosure of which could reasonably be expected to result in material financial loss or gain to, or could reasonably be expected to prejudice the competitive position of, a third party; or d) information the disclosure of which could reasonably be expected to interfere with contractual or other negotiations of a third party."
The nature of GlaxoSmithKline's adjuvant is a trade secret
Edited by serenbat - 3/19/13 at 10:57am